Trial Parameters
Condition Cardiogenic Shock
Sponsor Beijing Anzhen Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 20,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2017-01-01
Completion 2030-12-31
All Conditions
Interventions
ECMO
Brief Summary
Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.
Eligibility Criteria
Inclusion Criteria: * Patients receiving ECMO for circulatory and/or respiratory support Exclusion Criteria: * Refusal of consent
Related Trials
NCT05185492
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
View Trial →
NCT06081205
Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
View Trial →
NCT04158479
China Extracorporeal Life Support Registry
View Trial →